Creatine Maintenance Dose: Why 3-5g/Day Works for Most People

The Physiology of Creatine Turnover

The human body contains a total creatine pool of approximately 120-140 g in a 70 kg individual. Of this, roughly 95% resides in skeletal muscle, with the remainder distributed across the brain, kidneys, liver, and testes. Each day, approximately 1.7% of the total creatine and phosphocreatine pool undergoes irreversible, non-enzymatic degradation to creatinine, which is then excreted by the kidneys. For a person with a total pool of 120 g, this equates to roughly 2 g/day of creatine turnover.

Under normal dietary conditions, the body replaces this daily loss through two pathways. Endogenous synthesis, primarily in the liver and kidneys via the arginine-glycine amidinotransferase (AGAT) and guanidinoacetate N-methyltransferase (GAMT) enzyme system, produces approximately 1 g/day. Dietary intake from meat and fish contributes an additional 1-2 g/day in omnivores, though this figure varies substantially depending on food choices. Vegetarians receive negligible dietary creatine, relying entirely on endogenous synthesis.

When muscle creatine stores are elevated through supplementation (from approximately 120 to 150 mmol/kg dry weight), the daily turnover rate increases in absolute terms because it is proportional to the total pool size. The elevated pool of roughly 140-160 g produces approximately 2.4-2.7 g/day of creatinine. Maintaining these elevated stores therefore requires replacing this higher absolute loss.

Why 3-5 g/Day Is Sufficient

The maintenance dose recommendation of 3-5 g/day originates from the work of Hultman et al. (1996), who demonstrated that after a five-day loading phase of 20 g/day, a subsequent daily dose of 2 g was sufficient to maintain elevated muscle creatine stores over a 28-day monitoring period. They noted that slightly higher doses (3-5 g/day) provided a greater margin of safety for individuals with larger muscle mass or higher turnover rates.

The International Society of Sports Nutrition (ISSN) formalized this recommendation in their 2017 position stand (Kreider et al., 2017), stating that a maintenance dose of 3-5 g/day of creatine monohydrate is effective for sustaining intramuscular creatine elevations in most individuals. The position stand drew on over two decades of supplementation trials and concluded that this dose range is both safe and effective for long-term use.

The arithmetic supports the recommendation. If daily turnover is approximately 2-2.7 g from the total pool, and endogenous synthesis replaces roughly 1 g of that, the exogenous replacement need is approximately 1-1.7 g/day at minimum. However, oral creatine bioavailability is not 100%. While absorption from the gut is generally high (estimated at 80-99% depending on the study), not all absorbed creatine reaches muscle tissue. Some is excreted renally before muscle uptake can occur. A dose of 3-5 g/day therefore provides a comfortable buffer above the calculated minimum requirement.

Body Weight and Muscle Mass Considerations

The 3-5 g/day range implicitly accounts for variation in body size. A 60 kg individual with moderate muscle mass has a smaller total creatine pool and lower absolute daily turnover than a 100 kg individual with substantial lean mass. The lighter person can maintain saturated stores near the lower end of the range (3 g/day), while the heavier person may benefit from the upper end (5 g/day) or even slightly more.

Kreider et al. (2017) noted that relative dosing of approximately 0.03 g/kg/day provides a more individualized estimate for maintenance. For a 70 kg person, this equals 2.1 g/day; for a 90 kg person, 2.7 g/day; and for a 110 kg person, 3.3 g/day. These calculated values are somewhat lower than the blanket 3-5 g recommendation, suggesting that the higher end of the range includes a safety margin. Given the negligible cost and absence of adverse effects at these doses, the practical recommendation of 3-5 g/day remains appropriate for simplicity.

Individuals with exceptionally high lean body mass (e.g., competitive bodybuilders above 100 kg) may theoretically benefit from 5-10 g/day to account for their larger creatine pool. However, direct evidence supporting maintenance doses above 5 g/day in any population is limited, and the ISSN position stand does not recommend exceeding 5 g/day for maintenance purposes in the general population.

Long-Term Maintenance Data

One of the most frequently asked questions about creatine supplementation is whether it remains effective and safe over months and years of continuous use. The evidence on this point is robust. Kreider et al. (2003) followed competitive athletes supplementing with creatine for up to 21 months and reported no adverse effects on any clinical health marker, including renal function, hepatic enzymes, lipid profiles, and hematological parameters.

Longer observational data exist. Poortmans and Francaux (1999) evaluated renal function in athletes who had been supplementing with creatine for periods ranging from 10 months to 5 years. They found no evidence of renal dysfunction as assessed by glomerular filtration rate, tubular reabsorption, or glomerular membrane permeability. Serum creatinine was modestly elevated (an expected consequence of increased creatine stores and turnover), but this did not reflect impaired kidney function.

The ISSN position stand (Kreider et al., 2017) concluded that creatine monohydrate is the most studied and clinically effective form of creatine for use in nutritional supplements, with a strong safety profile across all populations studied. They explicitly stated that long-term supplementation (up to five years) has been studied and appears safe in healthy individuals when taken at recommended doses.

Does Endogenous Synthesis Downregulate?

A persistent concern is whether chronic exogenous creatine intake suppresses the body's own creatine production. The AGAT enzyme, which catalyzes the first step of endogenous creatine synthesis, is subject to feedback inhibition by creatine. In vitro and animal studies have confirmed that elevated intracellular creatine concentrations reduce AGAT expression and activity.

However, this suppression is reversible. Cessation of exogenous creatine supplementation leads to a return of endogenous synthesis to baseline levels within weeks. Vandenberghe et al. (1997) documented that muscle creatine levels returned to pre-supplementation values within four to six weeks of ceasing supplementation, and this timeline is consistent with restored endogenous production. There is no evidence in humans that chronic creatine supplementation permanently impairs the body's ability to synthesize creatine.

From a clinical perspective, the temporary reduction in endogenous synthesis during supplementation is actually metabolically favorable. Creatine synthesis is metabolically expensive, consuming methyl groups from S-adenosylmethionine (SAM) and requiring arginine and glycine as substrates. Reducing this synthetic burden frees methyl groups and amino acids for other metabolic processes. Brosnan et al. (2011) estimated that creatine synthesis accounts for approximately 40% of all SAM-derived methyl groups in the body, making exogenous supplementation a meaningful reduction in methylation demand.

Maintenance Without Prior Loading

An important clarification: the 3-5 g/day maintenance dose is not exclusively a follow-up to loading. As Hultman et al. (1996) demonstrated, taking 3 g/day without any loading phase gradually elevates muscle creatine stores over approximately 28 days until they reach the same saturation level achieved by loading. After that point, continued intake of 3-5 g/day serves the same maintenance function regardless of how saturation was initially achieved.

This means the distinction between "loading" and "maintenance" is primarily one of timeline. The maintenance dose is the long-term daily intake that matches turnover. If started from unsupplemented baseline, this dose will simultaneously saturate and maintain. If started after loading, it maintains the already-saturated state. The biochemical endpoint is identical.

Timing of the Maintenance Dose

At the maintenance level of 3-5 g/day, timing is less pharmacokinetically critical than during loading. A single daily dose produces a plasma creatine peak that is cleared within several hours, but because the goal is to replace approximately 2 g of daily turnover (not to rapidly fill a deficit), consistent daily intake matters more than precise timing.

That said, some evidence suggests modest advantages to post-exercise timing. Antonio and Ciccone (2013) reported small but statistically significant benefits in lean mass and strength when creatine was consumed immediately after resistance training compared to immediately before. The proposed mechanism involves exercise-induced increases in muscle blood flow and creatine transporter activity. However, the effect size is small, and the practical significance for the average user is marginal. The most important factor is daily consistency.

What Happens If You Miss Days

Missing occasional doses has minimal impact on intramuscular stores. Because the creatine pool is large (120-160 g) and turnover is slow (approximately 2 g/day), a single missed day reduces the pool by roughly 1-2 g (the shortfall between turnover loss and endogenous synthesis alone). This represents less than 2% of the total pool. Even missing several consecutive days will not meaningfully deplete stores, provided supplementation is resumed promptly.

Complete cessation of supplementation, however, leads to a gradual return to baseline over approximately four to six weeks (Vandenberghe et al., 1997). This timeline is consistent with the daily turnover rate depleting the 20-40 g of additional creatine stored during supplementation. Regular daily intake is therefore preferable, but occasional missed doses are inconsequential.

Practical Recommendations

The maintenance protocol is straightforward:

1. Consume 3-5 g of creatine monohydrate daily. For most individuals (60-90 kg), 3-5 g is appropriate. Larger individuals (above 90 kg) may benefit from staying at the upper end.
2. Take the dose at a consistent time each day to build a sustainable habit. With meals is practical but not required.
3. Dissolve in water, juice, or any beverage. Creatine monohydrate is stable in solution for reasonable periods.
4. Continue indefinitely. There is no evidence-based reason to cycle off maintenance dosing.
5. Do not exceed 5 g/day for maintenance. Higher doses provide no additional benefit once stores are saturated and simply increase renal excretion.

Summary

The 3-5 g/day maintenance dose is grounded in the physiology of creatine turnover. The body degrades approximately 2 g of creatine daily, and a 3-5 g exogenous dose — after accounting for endogenous synthesis and bioavailability losses — reliably replaces this deficit and sustains elevated intramuscular stores. Long-term safety data spanning years of continuous use support indefinite supplementation at this dose. The recommendation is consistent across the ISSN position stand, meta-analyses, and two decades of clinical trials.

Bibliography

1. Hultman E, Soderlund K, Timmons JA, Cederblad G, Greenhaff PL. Muscle creatine loading in men. Journal of Applied Physiology. 1996;81(1):232-237. doi:10.1152/jappl.1996.81.1.232. PMID: 8828669.
2. Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. Journal of the International Society of Sports Nutrition. 2017;14:18. doi:10.1186/s12970-017-0173-z. PMID: 28615996.
3. Kreider RB, Melton C, Rasmussen CJ, et al. Long-term creatine supplementation does not significantly affect clinical markers of health in athletes. Molecular and Cellular Biochemistry. 2003;244(1-2):95-104. doi:10.1023/A:1022469320296. PMID: 12701816.
4. Poortmans JR, Francaux M. Long-term oral creatine supplementation does not impair renal function in healthy athletes. Medicine and Science in Sports and Exercise. 1999;31(8):1108-1110. doi:10.1097/00005768-199908000-00005. PMID: 10449011.
5. Vandenberghe K, Goris M, Van Hecke P, Van Leemputte M, Vangerven L, Hespel P. Long-term creatine intake is beneficial to muscle performance during resistance training. Journal of Applied Physiology. 1997;83(6):2055-2063. doi:10.1152/jappl.1997.83.6.2055. PMID: 9390981.
6. Antonio J, Ciccone V. The effects of pre versus post workout supplementation of creatine monohydrate on body composition and strength. Journal of the International Society of Sports Nutrition. 2013;10:36. doi:10.1186/1550-2783-10-36. PMID: 23919405.
7. Brosnan JT, da Silva RP, Brosnan ME. The metabolic burden of creatine synthesis. Amino Acids. 2011;40(5):1325-1331. doi:10.1007/s00726-011-0853-y. PMID: 21387089.